Bahrain Pharmaceuticals & Healthcare Report Q4 2013 - New Report Available
Bahrain will remain import-reliant for its pharmaceutical needs. While its small population size is a limiting factor, the entrenched preference for patented products will continue to stimulate foreign research-based companies interest in the local pharmaceutical market. Some investors will, however, remain vary on account of the ongoing political tensions in the country.
View full press release